Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor.
- 1 January 1998
- journal article
- Published by Springer Nature in Inflammation
- Vol. 22 (5), 483-491
- https://doi.org/10.1023/a:1022346010304
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.1997
- The Tumor Necrosis Factor Ligand and Receptor FamiliesNew England Journal of Medicine, 1996
- Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques.1993
- Effects of tumour necrosis factor and interleukin-1 on von Willebrand factor secretion from human vascular endothelial cells.1991
- Effects of tumor necrosis factor on prostacyclin production and the barrier function of human endothelial cell monolayers.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro.1991
- Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.The Journal of Immunology, 1991
- A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicityJournal of Biological Chemistry, 1989
- von Willebrand factor is an acute phase reactant in manThrombosis Research, 1989
- Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986